The ROC analysis showed that PTX3 achieved good prediction efficacy to distinguish tumor from normal (AUC > 0.80) for BRCA, CHOL, COAD, KICH, LUSC, and THCA (Supplementary Figure S1). This evidence concerns the gene PTX3 and neoplasm.